STOCK TITAN

Actinium Pharmaceuticals, Inc (ATNM) Net Income by Year

ATNM

Actinium Pharmaceuticals, Inc reported a net loss of $33.9M in fiscal year 2025. This represents an increase of 11.4% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Actinium Pharmaceuticals, Inc has filed alongside them.

FY2025 annual
Net Income -$33.9M
YoY +11.4%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ATNM Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$33.9M+11.4%-$38.2M+21.7%-$48.8M-47.9%-$33.0M-33.3%-$24.8M-11.5%-$22.2M-1.4%-$21.9M+7.4%-$23.7M+11.1%-$26.6M-9.4%-$24.3M-15.7%-$21.0M+14.8%-$24.7M-129.1%-$10.8M-28.9%-$8.4M-142.7%-$3.4M

ATNM Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income$27.9M+505.7%-$5.5M+65.4%N/A-$5.1M+55.6%-$6.9M+39.4%-$15.9M-83.8%N/A-$11.6M+12.9%-$11.4M+25.2%-$8.7M+21.4%N/A-$13.3M-40.1%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Actinium Pharmaceuticals, Inc financials

Frequently Asked Questions

What was Actinium Pharmaceuticals, Inc's net income in fiscal year 2025?

Actinium Pharmaceuticals, Inc reported a net loss of $33.9M in fiscal year 2025.

How fast is Actinium Pharmaceuticals, Inc's net income growing?

Actinium Pharmaceuticals, Inc (ATNM) net income rose by 11.4% year over year, from -$38.2M to -$33.9M in fiscal year 2025.

How has Actinium Pharmaceuticals, Inc's net income changed over the years?

Across the 15 fiscal years this page covers, Actinium Pharmaceuticals, Inc (ATNM) net income went from -$3.4M in fiscal year 2011 to -$33.9M in fiscal year 2025.

Actinium Pharmaceuticals, Inc (ATNM) reported $27.9M in net income in Q2 2026. This represents an increase of 505.7% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Actinium Pharmaceuticals, Inc (ATNM) reported on that line in every period on record.